States and cities sue over Trump’s EPA eliminating rule that limits emissions from power plants

In an effort to prevent potential restrictions on accessing prescription medications from international pharmacies, several lawmakers are urging the Trump administration to reconsider a forthcoming federal rule. This rule mandates that medicines mailed from abroad undergo a customs process, which requires a licensed customs broker and a financial guarantee through an entry bond.

This additional step and associated cost pose a challenge for American citizens who have traditionally been able to obtain prescriptions from Canada and other countries without significant difficulties, primarily to save money on expensive drugs. The call for importing medications gained momentum over two decades ago when drug prices began to rise, leading some Americans to travel to Canada by bus in pursuit of more affordable medications.

However, under present legislation, importing medicine into the U.S. for personal use remains illegal in most cases due to the lack of approval by the U.S. Food and Drug Administration for safety and effectiveness. Further details can be found in the full STAT+ article.